Tech Company Financing Transactions
TaiGen Biotechnology Funding Round
TaiGen Biotechnology secured a $38 million Series B funding round on 3/16/2004. Investors included MPM Capital.
Transaction Overview
Company Name
Announced On
3/16/2004
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Series B
Investors
MPM Capital (Lead Investor)
Proceeds Purpose
TaiGen intends to use the funds to continue the internal R&D programs and clinical development of in-licensed drug candidates, focusing on immune disorders, cancer and viral infection.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7F 138 Shin Ming Rd. Neihu Dist.
Taipei City, 114 R.O.C.
Taiwan
Taipei City, 114 R.O.C.
Taiwan
Phone
Website
Email Address
Overview
TaiGen Biotechnology Company Ltd. is a research-based and product-driven biopharmaceutical company based in Taiwan.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philip Huang
VP - Bus. Development
Peter Tsao
VP - Finance
Richard Lu
VP - R & D
Chu-Chung Lin
Browse more venture capital transactions:
Prev: 3/16/2004: NetScaler venture capital transaction
Next: 3/16/2004: Semcasting venture capital transaction
Share this article
News on VC Transactions
We report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs